← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Children'S Hospital Corporation, The
$110,380,985
Total funding
84
Grants
Funding over time
peak $22.5M · FY2008–25$25M$18.8M$12.5M$6.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$109,776,744 · 81
DOE$544,242 · 2
NASA$59,999 · 1
By mechanism
—$110,380,985 · 84
Investigators at Children'S Hospital Corporation, The
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
MULTICENTER RANDOMIZED TRIAL OF EVEROLIMUS IN PEDIATRIC HEART TRANSPLANTATION$10,075,335
· FY2017 · Defense Health Agency
TITRE: TRIAL OF INDICATION-BASED TRANSFUSION OF RED BLOOD CELLS IN ECMO$8,927,797
· FY2022 · Defense Health Agency
BREAST CANCER REVERSAL BY ENGINEERING THE TUMOR MICROENVIRONMENT$8,313,722
· FY2008 · Department of Defense
GENE THERAPY FOR CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR$5,278,464
· FY2019 · Department of the Army
PREVENTION OF THE ANGIOGENIC SWITCH IN HUMAN BREAST CANCER$4,967,019
· FY2008 · Department of Defense
PHARMACEUTICAL DEVELOPMENT OF INJECTABLE OXYGEN IN PREPARATION FOR CLINICAL TESTING$4,786,376
· FY2019 · Defense Health Agency
ANGIOGENESIS RESEARCH TO IMPROVE THERAPIES FOR VASCULAR LEAK SYNDROMES, INTRA-ABDOMINAL ADHESIONS, AND ARTERIAL INJURIES$4,715,840
· FY2008 · Department of Defense
ADVANCED DEVELOPMENT OF MITOCHONDRIAL MONITOR TO DETECT SHOCK STATES USING RESONANCE RAMAN SPECTROSCOPY$3,566,096
· FY2019 · Defense Health Agency
AN INTEGRATED APPROACH TOWARD IDENTIFYING BIOPSYCHOSOCIAL ASPECTS OF PAIN IN FIBROUS DYSPLASIA/MCCUNE-ALBRIGHT SYNDROME$3,062,579
· FY2025 · Defense Health Agency
FROM MOLECULAR MECHANISM TO THERAPY FOR BARTH SYNDROME$2,788,724
· FY2021 · Department of the Army
OPTIMIZATION AND TESTING OF INJECTABLE OXYGEN GAS MICROPARTICLES FOR ACUTE RESPIRATORY FAILURE$2,256,651
· FY2015 · Department of the Army
RBFOX GENES IN CONGENITAL HEART DISEASE AND CARDIOMYOPATHY$2,124,000
· FY2020 · Department of the Army
VACCINES FOR PSEUDOMONAS AERUGINOSA$1,883,749
· FY2019 · Department of the Army
BRAIN CONSEQUENCES OF SPINAL CORD INJURY WITH AND WITHOUT NEUROPATHIC PAIN: TRANSLATING ANIMAL MODELS OF NEUROINFLAMMATION ONTO HUMAN NEURAL NETWORKS$1,855,650
· FY2015 · Department of the Army
BREAST CANCER: CATCH IT WITH ULTRASOUND$1,733,158
· FY2010 · Department of Defense
NOVEL, NON-HORMONAL THERAPY FOR THE TREATMENT OF CHRONIC PAIN DUE TO ENDOMETRIOSIS IN ADOLESCENT AND ADULT WOMEN$1,685,664
· FY2019 · Defense Health Agency
IMPROVING NEURODEVELOPMENTAL OUTCOMES IN CHILDREN WITH CONGENITAL HEART DISEASE: AN INTERVENTION STUDY$1,634,995
· FY2016 · Department of the Army
MOLECULAR CONTROL OF OPTIC NERVE REGENERATION$1,500,000
· FY2016 · Department of the Army
DEVELOPMENT OF NOVEL LOCAL ANALGESICS FOR MANAGEMENT OF ACUTE TISSUE INJURY PAIN$1,500,000
· FY2015 · Department of Defense
DEFINING EARLY MARKERS OF NEURODEVELOPMENTAL DISORDERS IN INFANTS WITH TSC$1,473,426
· FY2011 · Department of Defense